Safety and Immunogenicity Study of GX-70 in TB Patient
Status:
Withdrawn
Trial end date:
2018-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the safety, tolerability, and immunogenicity in
patients with pulmonary tuberculosis of an investigational DNA vaccine being developed for
the prevention of relapse of tuberculosis.